98 related articles for article (PubMed ID: 10754453)
1. Pharmacological properties of the gastric H(+)/K(+) ATPase inhibitor, AU-461.
Cheon HG; Kim HJ; Mo HK; Lee BH; Choi J
Pharmacology; 2000 Apr; 60(3):161-8. PubMed ID: 10754453
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
Cheon HG; Lee SS; Lim H; Lee DH
Eur J Pharmacol; 2001 Jan; 411(1-2):187-192. PubMed ID: 11137875
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological studies on the new quinoline derivative 1-(2-methylphenyl)-4-[(3-hydroxypropyl) amino]-6-trifluoromethoxy-2,3-dihydropyrrolo[3,2-c] quinoline with potent anti-ulcer effect.
Cheon HG; Kim HJ; Kim SS; Choi JK; Kong JY
Arzneimittelforschung; 1998 Dec; 48(12):1168-71. PubMed ID: 9893932
[TBL] [Abstract][Full Text] [Related]
6. Anti-ulcer activity of newly synthesized acylquinoline derivatives.
Cheon HG; Kim HJ; Mo HK; Shin E; Lee Y
Arch Pharm Res; 1999 Apr; 22(2):137-42. PubMed ID: 10230503
[TBL] [Abstract][Full Text] [Related]
7. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
[TBL] [Abstract][Full Text] [Related]
9. Effects of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion and gastroduodenal ulcers in rats.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
Methods Find Exp Clin Pharmacol; 1999 Mar; 21(2):115-22. PubMed ID: 10327392
[TBL] [Abstract][Full Text] [Related]
10. Antiulcerogenic and ulcer healing effects of Solanum nigrum (L.) on experimental ulcer models: possible mechanism for the inhibition of acid formation.
Jainu M; Devi CS
J Ethnopharmacol; 2006 Mar; 104(1-2):156-63. PubMed ID: 16202548
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
[TBL] [Abstract][Full Text] [Related]
12. ME-3407, a new antiulcer agent, inhibits acid secretion by interfering with redistribution of H(+)-K(+)-ATPase.
Urushidani T; Muto Y; Nagao T; Yao X; Forte JG
Am J Physiol; 1997 May; 272(5 Pt 1):G1122-34. PubMed ID: 9176222
[TBL] [Abstract][Full Text] [Related]
13. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
14. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
[TBL] [Abstract][Full Text] [Related]
15. The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol e.
Chung YK; Chang MS; Kim KB; Sohn SK; Woo TW; Lee SB; Choi WS
Can J Physiol Pharmacol; 1998 Sep; 76(9):921-9. PubMed ID: 10066143
[TBL] [Abstract][Full Text] [Related]
16. Antiulcer and gastric antisecretory effects of dichloromethane fraction and piplartine obtained from fruits of Piper tuberculatum Jacq. in rats.
Burci LM; Pereira IT; da Silva LM; Rodrigues RV; Facundo VA; Militão JS; Santos AR; Marques MC; Baggio CH; Werner MF
J Ethnopharmacol; 2013 Jun; 148(1):165-74. PubMed ID: 23588092
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
18. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gastric acid secretion by a standardized aqueous extract of Cecropia glaziovii Sneth and underlying mechanism.
Souccar C; Cysneiros RM; Tanae MM; Torres LM; Lima-Landman MT; Lapa AJ
Phytomedicine; 2008 Jun; 15(6-7):462-9. PubMed ID: 18462931
[TBL] [Abstract][Full Text] [Related]
20. Gastric antisecretory and antiulcer/cytoprotective effects of 2-cyano-3-(ethylthio-3-methylthio)-2-propenoic acid methyl ester.
Borella LE; DiJoseph JF
Arzneimittelforschung; 1989 May; 39(5):598-601. PubMed ID: 2547390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
